Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia

Maximilien Tailler; Laura Senovilla; Élodie Lainey; Sylvain Thépot; David Métivier; Marie Sébert; Véronique Baud; Katy Billot; Pierre Fenaux; Lorenzo Galluzzi; Simone Boehrer; Guido Guido Kroemer; Oliver Kepp

doi:10.1038/onc.2011.521

Related publications

Article2016

Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia

Ana Espírito Santo, Sérgio Chacim, Isabel Cristina Fernandes Rodrigues Ferreira, Luís Leite, Cláudia Moreira, Dulcineia Pereira, Margarida Brito, Marta C. Nunes, Nélson Domingues, Isabel Oliveira, Ilídia Moreira, Ângelo Martins, Luísa Viterbo, José Mariz, Rui Medeiros

Article2011

Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia

Sylvain Thépot, Élodie Lainey, Thomas Cluzeau, Marie Sébert, Carole Leroy, Lionel Adès, Maximilien Tailler, Lorenzo Galluzzi, Fanny Baran‐Marszak, Hervé Roudot, Virginie Éclache, Claude Gardin, Stéphane de Botton, Patrick Auberger, Pierre Fenaux, Guido Guido Kroemer, Simone Boehrer

Article2012

Antineoplastic activity of ouabain and pyrithione zinc in acute myeloid leukemia

Discussion(0)

Related publications

Effect of therapy-related acute myeloid leukemia on the outcome of patients with acute myeloid leukemia

Hypomethylating agents reactivate FOXO3A in acute myeloid leukemia

Erlotinib antagonizes ABC transporters in acute myeloid leukemia

Azacytidine and erlotinib exert synergistic effects against acute myeloid leukemia

Heterogeneous leukemia stem cells in myeloid blast phase chronic myeloid leukemia